Telomerase activity in normal leukocytes and in hematologic malignancies

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Telomeres protect chromosome ends and shorten with cell division without telomerase.
• Telomere shortening contributes to cellular senescence and limits proliferation.
• Telomerase activity is linked to cellular immortality and has been observed in cancer cells.

Purpose of the Study:

• To investigate the temporal expression pattern of telomerase in hematologic malignancies.
• To correlate telomerase activity with disease progression in specific blood cancers.
• To understand the role of telomere maintenance in the evolution of hematologic malignancies.

Main Methods:

• Analysis of telomerase activity in leukocytes from normal donors and patients with chronic lymphocytic leukemia (CLL), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML).
• Comparison of telomerase levels across different stages of disease progression.
• Assessment of telomere length dynamics in relation to disease progression.

Main Results:

• Normal leukocytes exhibit low telomerase activity.
• Leukocytes in early CLL and MDS show lower telomerase activity than controls, increasing in late-stage disease.
• Telomerase activity is significantly enhanced in AML compared to normal bone marrow.
• Telomeres consistently shorten with disease progression across all studied hematologic malignancies, irrespective of telomerase levels.

Conclusions:

• Early-stage CLL and MDS cells possess inefficient telomere maintenance mechanisms.
• Telomerase activation appears to be a late event in the progression of CLL and MDS, likely driven by selective pressure for immortality due to critical telomere loss.
• The findings highlight distinct telomere maintenance strategies in different hematologic malignancies.